1. Effect of Lansoprazole on the Control of the Intragastric pH in a Patient with Short Bowel Syndrome
- Author
-
Masato Yoshioka, Masatake Iida, Fumitaka Yagi, Go Watanabe, Yasuhiko Nakagawa, Tasuku Watanabe, Hiroshi Uchinami, Naohiro Yokoyama, Yuzo Yamamoto, and Yuki Abe
- Subjects
Adult ,Male ,Short Bowel Syndrome ,medicine.medical_specialty ,gastric juice ,Lansoprazole ,Case Report ,030204 cardiovascular system & hematology ,Gastroenterology ,Gastric Acid ,03 medical and health sciences ,0302 clinical medicine ,proton pump inhibitor (PPI) ,Internal medicine ,Internal Medicine ,medicine ,Humans ,short bowel syndrome (SBS) ,Holding time ,business.industry ,pH monitor ,General Medicine ,Hydrogen-Ion Concentration ,lansoprazole ,Anti-Ulcer Agents ,Short bowel syndrome ,medicine.disease ,Small intestine ,medicine.anatomical_structure ,Parenteral nutrition ,Quality of Life ,Gastric acid ,030211 gastroenterology & hepatology ,Watery diarrhea ,business ,medicine.drug - Abstract
A 40-year-old man suffered from short bowel syndrome. Since a large amount of intestinal output and watery diarrhea hampered his quality of life, we tried to control the intestinal output by reducing the secretion of gastric acid with lansoprazole. Because the small intestine was only 10 cm in length and effective absorption of oral lansoprazole was doubtful, we monitored his intragastric pH for 24 hours and confirmed that the holding time above pH 3.0 was 14.5 hours (60.4%). He spent his home life eating porridge during the day, and receiving total parenteral nutrition of 1,100 mL/day at night while taking lansoprazole as an oral tablet (30 mg) once a day.
- Published
- 2019